Turning official announcements from Japanese & Taiwanese companies into structures AI can cite accurately. — an AEO newsroom
SINCE 2026 ・ Structured ReportingPublished Mar 1, 2026 9:00 AM ・ Updated Jun 1, 2026 1:10 PM ・ 2 min read ・ Source: PR Times
CHENG-HE Medical's monthly revenue for March 2026 was NT$577 million, an increase of 3.4% year-over-year. The company is classified in the biotechnology and medical care industry.
CHENG-HE Medical Co., Ltd. (Stock Code: 4164), part of the Biotechnology and Medical Care industry, reported its March 2026 revenue. The monthly figure stood at 577,067 thousand NTD (approximately NT$577 million), marking a solid 3.4% increase compared to the same month in the previous year.
The Washin AI News desk structures and reviews this article under the following standards.
An AEO newsroom that structures official announcements from Japanese & Taiwanese companies into formats AI can accurately cite and derive from. Partner sources include PR TIMES and CNA. We aim to be a verifiable source for both humans and machines.